Unilabs News | Unilabs

Unilabs News

Unilabs is constantly striving to improve healthcare through innovation in diagnostics. Here we share out latest innovations and news. For media enquiries, please contact our press office.

Blog
15 September 2021
#WEWON’TREST IN THE FIGHT AGAINST COVID-19
Since the beginning of the pandemic, our teams have been on the frontlines of Covid-19 testing and diagnosis. We have relentless performed PCR, antibody, and antigen tests – and our data has helped the medical authorities track the spread of variants – helping them put in place targeted measures to contain the virus.
Blog
9 September 2021
The pros and cons of e-health applications
If the Covid-19 pandemic has shown us anything, it’s the importance of digital healthcare – which allows patients to get the treatment they need even when they can’t go see a doctor.
Blog
1 September 2021
The digital doctor: future or pipedream?
It’s March 2020. The Coronavirus bursts onto the scene. Overnight, whole countries are locked down. Shops are shuttered. Offices close. Flights stop. The streets are empty. GPs close their practices. Hospitals batten down the hatches to focus on Covid and emergency care.
Blog
26 July 2021
In tune
Leading the field in diagnostics for over 30 years has required us to adapt quickly to the changing needs of our customers. At Unilabs, we pride ourselves on being a lean organisation where everybody – whatever their seniority – rolls up their sleeves to get things done.
Media Release
21 July 2021
Unilabs signs deal with Ibex to deploy AI-powered cancer diagnostics
Unilabs, a leading international provider of diagnostic services, and Ibex Medical Analytics, the pioneer in artificial intelligence-powered cancer diagnostics, have agreed a deal to implement Ibex’ AI platform in Europe.
Blog
15 July 2021
Like a Swiss watch
Swiss watches have a worldwide reputation. Switzerland has a distinguished history of horological innovation and excellence – boasting the most exquisite craftsmanship and a philosophy of continuous refinement.
Blog
12 July 2021
An extra pair of (digital) eyes - how AI will improve breast cancer screening
Imaging, a cornerstone of modern health care, is a rapidly evolving field. At Unilabs, we are part of this exciting journey – developing and evaluating new imaging techniques and innovations. Lately, AI has become an ever more promising tool to enhance medical imaging. The research community is working feverishly on how to take advantage of the possibilities of AI in the clinic. The goal is to provide modern, accurate diagnostics to our patients. And Unilabs is at the forefront of this evolution.
Media Release
8 July 2021
Unilabs launches mass vaccination drive-through in Porto, Portugal
Unilabs, the leading European diagnostic group, has opened a large-scale vaccination drive-through at the Queimódromo in Porto, Portugal, in partnership with ARS-Norte, Câmara Municipal do Porto, Hospital de São João, and Centro Hospitalar do Porto.
Blog
7 July 2021
The Quest for Innovation: The Latest Trends in Imaging and Radiotherapy
Faithful to its goal to be as creative, inventive, caring, and purpose-driven as the people who work there, TMC - Unilabs’ teleradiology arm – has sponsored the second report by the British Institute of Radiology and the BIR World Partner Network.
Media Release
28 June 2021
Unilabs launches new Covid-19 test to identify the Delta variant, supporting health authorities with data-driven pandemic response
Geneva, 29 June 2021: Unilabs, the leading European diagnostic services provider, has created a new PCR test that can specifically identify the new, more infectious Delta variant, and is working with health authorities to optimise public health measures accordingly.
Blog
23 June 2021
Keep on rolling
If you’re a healthcare professional, you may not know the bewilderment some of us go through when doctors throw medical jargon at us. All the poor patient wants to know is “am I OK or – or not?”
Media Release
18 June 2021
Unilabs appoints Michiel Boehmer as CEO; Jos Lamers becomes Chairman
Unilabs, the leading European diagnostic services provider, has formally appointed Michiel Boehmer, currently President and COO, as its new CEO.